Increased Exposure to PFAS, Phenols Linked to Prior Cancer Diagnosis
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 25, 2023 -- Per- and polyfluoroalkyl substances (PFAS), phenols, and parabens are associated with a previous cancer diagnosis, according to a study published online Sept. 18 in the Journal of Exposure Science & Environmental Epidemiology.
Amber L. Cathey, Ph.D., from the University of Michigan in Ann Arbor, and colleagues used data from the National Health and Nutrition Examination Survey to assess cross-sectional associations between biomarkers of PFAS, phenols, and parabens and self-reported previous cancer diagnoses among men and women aged 20 years and older. Concentrations of seven PFAS and 12 phenols/parabens were extracted, and the associated odds ratios for self-reported previous diagnoses of melanoma and cancers of the thyroid, breast, ovary, uterus, and prostate were assessed.
The researchers found that in women, greater perfluorodecanoic acid (PFDE), perfluorononanoic acid (PFNA), and perfluoroundecanoic acid (PFUA) were associated with increased odds of previous melanoma (odds ratios [ORs], 2.07, 1.72, and 1.76, respectively). Among women, a previous melanoma diagnosis was also linked to elevated levels of benzophenone-3 (BP3), 2,5-dichlorophenol (DCP25), and 2,4-dichlorophenol (ORs, 1.81, 2.41, and 1.85, respectively). In addition, the odds of previous ovarian cancer were increased in association with elevated levels of DCP25, bisphenol-A, and BP3 (ORs, 2.80, 1.93, and 1.76, respectively). Odds of previous uterine cancer were increased in association with increased PFNA (OR, 1.55), while the highest versus lowest category of ethyl paraben resulted in lower odds of uterine cancer (OR, 0.31).
"These PFAS chemicals appear to disrupt hormone function in women, which is one potential mechanism that increases odds of hormone-related cancers in women," Cathey said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Lower Prevalence of Employment Seen for Survivors of Childhood Cancer
FRIDAY, May 10, 2024 -- Adult survivors of childhood cancer have declines in employment and increases in health-related unemployment compared with the general population...
Large Language Models Fall Short in Breast Imaging Classification
FRIDAY, May 10, 2024 -- Large language models (LLMs) appear to fall short in classification of breast imaging, which can have a negative impact on clinical management, according...
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
THURSDAY, May 9, 2024 -- For patients with breast cancer, there are racial and ethnic differences in treatment declination, according to a study published online May 9 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.